Devyser Genomic Laboratories receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Hereditary cancer | September 30, 2022
Check out a recent publication from Capone et al from the University of Florence!
In this study, the Devyser BRCA test was used to analyze 227 patient DNA samples. They concluded that 100% of the expected SNVS and CNVS were detected and that the single-tube PCR-based library preparation format of the kit offers a decrease in processing time as well as a reduced risk of cross-contamination.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Read More
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Read More
Read More
Read More